Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.12 USD
4.95 M USD
433.14 M USD
77.76 M
About Organogenesis Holdings Inc.
Sector
Industry
CEO
Gary S. Gillheeney
Website
Headquarters
Canton
Founded
1985
FIGI
BBG00FGGD295
Organogenesis Holdings, Inc. is a regenerative medical company, which engages in the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. The company was founded in 1985 and is headquartered in Canton, MA.
$ORGO Basing Around it 50 MAAnother nice base around 50 MA on $ORGO
Cleary supply line @ that $17.50 level
Sales growth numbers catching my attention and stock is setting up
Symmetrical Triangle - Possible Breakout Possible Breakout .. practicing my Elliot Wave theory. Symmetrical Triangle
$ORGO Organogenesis Holdings Inc $20mil Insider Buys
$20 mil insider buys so far in November.
Alert set for break above $5.25
Targets-
$5.95 to gap fill
$6.63 Horizontal resistance
$7.00 Weekly candle resistance
INSIDER BUY DETAILS
Avista Capital Managing Member Director Nov 19 Buy 4.97 36,127 179,613 29,921,676 Nov 19 07:14 PM
Avista Capital M
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ORGO is 3.26 USD — it has increased by 1.56% in the past 24 hours. Watch Organogenesis Holdings Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Organogenesis Holdings Inc. stocks are traded under the ticker ORGO.
ORGO stock has risen by 12.80% compared to the previous week, the month change is a 9.03% rise, over the last year Organogenesis Holdings Inc. has showed a 46.19% increase.
We've gathered analysts' opinions on Organogenesis Holdings Inc. future price: according to them, ORGO price has a max estimate of 6.00 USD and a min estimate of 3.00 USD. Watch ORGO chart and read a more detailed Organogenesis Holdings Inc. stock forecast: see what analysts think of Organogenesis Holdings Inc. and suggest that you do with its stocks.
ORGO reached its all-time high on Jan 9, 2019 with the price of 310.90 USD, and its all-time low was 1.80 USD and was reached on Apr 26, 2023. View more price dynamics on ORGO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ORGO stock is 6.02% volatile and has beta coefficient of 1.20. Track Organogenesis Holdings Inc. stock price on the chart and check out the list of the most volatile stocks — is Organogenesis Holdings Inc. there?
Today Organogenesis Holdings Inc. has the market capitalization of 425.57 M, it has decreased by −1.07% over the last week.
Yes, you can track Organogenesis Holdings Inc. financials in yearly and quarterly reports right on TradingView.
Organogenesis Holdings Inc. is going to release the next earnings report on Nov 12, 2024. Keep track of upcoming events with our Earnings Calendar.
ORGO earnings for the last quarter are −0.13 USD per share, whereas the estimation was 0.01 USD resulting in a −2.70 K% surprise. The estimated earnings for the next quarter are −0.02 USD per share. See more details about Organogenesis Holdings Inc. earnings.
Organogenesis Holdings Inc. revenue for the last quarter amounts to 130.23 M USD, despite the estimated figure of 121.30 M USD. In the next quarter, revenue is expected to reach 108.83 M USD.
ORGO net income for the last quarter is −17.04 M USD, while the quarter before that showed −2.10 M USD of net income which accounts for −711.57% change. Track more Organogenesis Holdings Inc. financial stats to get the full picture.
No, ORGO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 8, 2024, the company has 862.00 employees. See our rating of the largest employees — is Organogenesis Holdings Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Organogenesis Holdings Inc. EBITDA is 38.47 M USD, and current EBITDA margin is 9.18%. See more stats in Organogenesis Holdings Inc. financial statements.
Like other stocks, ORGO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Organogenesis Holdings Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Organogenesis Holdings Inc. technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Organogenesis Holdings Inc. stock shows the buy signal. See more of Organogenesis Holdings Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.